Three Florida men, united under a common goal of helping advance cancer research, will be running the iconic 129th Boston ...

The U.S. Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients ...

More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or ...

Keegan Reilly is running not only in memory of his boss’ wife, but also for his grandmother, who is currently batting ...

ReAlta Life Sciences, Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute ...

Oncologists share how to prioritize yourself while undergoing the difficult treatment, and real women share how positive ...

The approval came on the bases of the results from the phase 3 CABINET study. The study compared cabozantinib to a placebo in ...

The Donald Trump administration has threatened Harvard with a cut of $9 billion in federal grants and contracts. The ...

But if a lawmaker happens to lead a nonprofit — as is the case for a handful of lawmakers on Beacon Hill — lobbyists and ...

With no portraits of Rhode Island theologian Roger Williams to go by, sculptor based image on the Splendid Splinter ...

Three Florida men, united under a common goal of helping advance cancer research, will be running the iconic 129th Boston ...

Generative artificial intelligence is aiding scientists in understanding proteins, potentially leading to improved cancer treatments and disease comprehension.